In our study, the 4-month-old APP/PS1 mice did not exhibit notable cognitive deficits, while the 4.5-month-old APP/PS1 mice did not show obviously decreased synaptophysin or increased phosphorylated tau levels but displayed deposition of amyloid plaques, which is consistent with previous studies. This evidence concerns the gene APP and Cognitive impairment.